Slingshot Insights | Lh Overview

LH Overview

Upcoming Projects (LH)

Second View: Discussing the first blood test for diagnosing Alzheimer’s disease, developed by Japan-based Fujirebio Diagnostics.
Tickers: DGX, LLY, BIIB, LH, QTRX, Fujirebio
Scheduled For: Sep 04, 2025 at 04:00 PM EDT

Executed Projects (LH)

Discussing the first blood test for diagnosing Alzheimer’s disease, developed by Japan-based Fujirebio Diagnostics.
Tickers: FUJIREBIO, LLY, BIIB, LH, DGX, QTRX
Executed On: Jun 20, 2025 at 12:00 PM EDT
Looking at the potential of LabCorp's amyloid-tau-neurodegeneration (ATN) profile test for Alzheimer’s disease diagnosis.
Tickers: LH, DGX, QTRX, C2N Diagnostics
Executed On: Jan 09, 2024 at 04:30 PM EST

Upcoming & Overdue Catalysts (LH)

Don’t see a catalyst related to the company you care about? Create your own!

Occurred Catalysts (LH)

LabCorp Announces The CDC Zika MAC-ELISA Test Has Received FDA Emergency Use Authorization and Complements the RealStar Zika Virus RT-PCR Kit U.S.
Ticker: LH
Occurred on: Aug 02, 2016

Strategic Initiatives (LH)

LabCorp (LH) Agrees to Acquire Pathology Associates Medical Laboratories from Providence Health & Catholic Health Initiatives
Tickers: LH, Providence Health, Catholic Health Initiatives
Announcement Date: Feb 24, 2017
LabCorp (LH) Agrees to Purchase Clinical Outreach Laboratories from Mount Sinai Health System for Undisclosed Sum
Tickers: LH, Mount Sinai Health System
Announcement Date: Jan 10, 2017
LabCorp Announces Agreement To Acquire Sequenom
Tickers: SQNM, LH
Announcement Date: Jul 27, 2016